Acclaim Infusion Pump Recall Issued Due to Potentially Fatal Delays

The FDA is warning that Acclaim infusion pumps sold by Abbott and Hospira may place patients at a risk of serious injury or death, due to broken doors that may delay the delivery of medication or cause drug overdose.  

Last week, the FDA determined that an Acclaim Infusion Pump recall should be classified as a class 1 medical device recall. The classification means the agency believes that the problems with the pump could lead to serious injury or death. However, neither the FDA nor Hospira are aware of any actual injuries or deaths that may be associated with the problem.

The infusion pumps are used to deliver medications, blood or blood products and other medical fluids into a patient’s body. The original recall was issued on October 31, 2013, following customer reports of broken door assemblies. If the door is not closing properly, it could lead to over-infusion or a delay in treatment. Either of these problems could result in fatal injuries for some patients.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

The recall affects Abbott Acclaim Infusion Pumps and Hospira Acclaim Encore Infusion Pumps with list numbers 12032 and 12237. The affected Abbott pumps were manufactured from February 1998 to November 1998 and distributed from September 1998 through February 2004. Affected Hospira infusion pumps were manufactured from February 1997 through February 2010 and distributed from July 1999 through November 2013.

Hospira provided customers with instructions on how to check the infusion pump for cracks before programming therapy. The company also called on customers to make sure that health care professionals that might use the device be aware of the problem. Those who find their devices are damaged should stop using them immediately and call Hospira at (800) 441-4100.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Abbott May Remove Infant Formula for Preemies Off the Market Due to Similac NEC Lawsuits
Abbott May Remove Infant Formula for Preemies Off the Market Due to Similac NEC Lawsuits (Posted today)

Abbott Laboratories is considering removing Similac infant formula products designed for preterm babies from the market, as it faces hundreds of lawsuits claiming the products increase the risk of necrotizing enterocolitis, which puts newborns at a high risk of permanent injuries and death.

Information About Suboxone Dental Claims To Be Exchanged By Parties in MDL
Information About Suboxone Dental Claims To Be Exchanged By Parties in MDL (Posted yesterday)

A federal judge has ordered parties involved in Suboxone dental decay lawsuits to submit proposals for exchanging information that will guide the selection of representative bellwether claims for early test trials.

Master Baby Food Lawsuit Filed in MDL Outlines How Toxic Metals Caused Autism, ADHD in Children
Master Baby Food Lawsuit Filed in MDL Outlines How Toxic Metals Caused Autism, ADHD in Children (Posted 4 days ago)

Plaintiffs have submitted a baby food lawsuit Master Complaint that is expected to streamline the filing of lawsuits alleging that toxic heavy metals in Beech-Nut, Gerber, Hain and Nurture products caused ADHD, autism and other developmental disorders.